Table 2. Characteristics of the fecal bacterial signals between the donors at the beginning and end of the study, and patients in weeks 0, 1, 3, 12 and 20/28.
Bacteria strain |
Donors, Beginning of study, n = 13 |
Patients | Donors, End of study, n = 10 |
Pa Before FMT | Pb After 1 week | Pc After 3 weeks | Pd After 12 weeks | Pe After 20/28 weeks | Pf Donors | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FMT day, n = 9 | After 1 week, n = 12 | After 3 weeks, n = 9 | After 12 weeks, n = 13 | After 20/28 weeks, n = 12 | |||||||||
Ruminococcus gnavus | 4.6±1.1 | 40±15.6 | 8±2.3 | 15.3±9 | 25±17 | 8.1±1.8 | 8.8±2 | 0.015 | >0.9 | 0.15 | 0.44 | >0.9 | 0.19 |
Bacteroides | 27.2±4.1 | 38.9±8.3 | 47.1±16.6 | 30.9±3.7 | 55.4±12.7 | 49.3±11 | 42±5.2 | >0.9 | >0.9 | >0.9 | 0.02 | 0.1 | 0.097 |
Bacteroides/Prevotella | 483±51.4 | 634±28.5 | 599±25.8 | 551±63.9 | 783±49.7 | 731±52 | 788±58 | 0.7 | >0.9 | >0.9 | 0.005 | 0.02 | 0.009 |
Alistipes | 100.5±16.8 | 100.5±23 | 119±17.4 | 140±26.8 | 186±11.9 | 208±9.6 | 188±15.5 | >0.9 | >0.9 | 0.9 | 0.011 | 0.0006 | 0.03 |
Parabacteroides | 7.6±1.8 | 7.9±2.9 | 8.3±2 | 14.6±5.4 | 11.8±1.8 | 15.7±3.5 | 19.5±3.8 | >0.9 | >0.9 | >0.9 | 0.4 | 0.3 | 0.03 |
Actinobacteria | 287±45 | 66.6±13 | 95±23 | 197±54 | 138±29 | 92±23 | 204±57 | 0.0010 | 0.007 | 0.7 | 0.2 | 0.003 | 0.018 |
Bifidobacteria | 324±57 | 65±13 | 97±25 | 205±57 | 150±34 | 92.5±25 | 241±72 | 0.0011 | 0.008 | 0.6 | 0.2 | 0.004 | 0.017 |
Proteobacteria | 27±7.8 | 195±121.6 | 565±162 | 63.8±28.5 | 105±70 | 56.5±40 | 17±1.9 | >0.9 | 0.03 | >0.9 | 0.9 | >0.9 | 0.5 |
Shigella/Escherichia | 62±23 | 260±124 | 578±128 | 116±45 | 188±77 | 90.9±65 | 41±14 | >0.9 | 0.002 | 0.8 | >0.9 | >0.9 | 0.8 |
Data are presented as the mean±SEM. Comparison: Kruskal-Wallis multiple comparisons test with Dunn’s post test
a Donors at the beginning of the study vs. patients on FMT day before fecal installation.
b Donors at the beginning of the study vs. patients 1 week after FMT.
c Donors at the beginning of the study vs. patients 3 weeks after FMT.
d Donors at the beginning of the study vs. patients 12 weeks after FMT.
e Donors at the beginning of the study vs. patients 20/28 weeks after FMT.
Paired t test
f Donors at the beginning vs. end of the study.
FMT: fecal microbiota transplantation.